The media often use terms like holy grail, silver bullet, or dawn of a new age in… for new treatments that seemingly offer a cure to a given ailment without any concomitant adverse effects. This trend is particularly noticeable in oncology, with Time magazine’s front cover from May 2001 perhaps being the most famous example. However, oncology is not the only therapy area where this is apparent.
Between May 2019 and March 2020, The Corpus ran an educational programme in atherosclerotic cardiovascular disease (ASCVD) in the Japan-Asia Pacific region. As with many of our online meetings, these were designed to be intimate and interactive affairs with a group of approximately 20 healthcare professionals at each one-hour meeting. Addressing an identified unmet need, the focus on the series was managing low-density lipoprotein cholesterol (LDL-C) levels in patients with ASCVD and reached more than 600 healthcare professionals (HCPs) across the region.
Since March 2020, public interest in healthcare has skyrocketed. Prior to the pandemic, much of the population had little to no interest in the results of immunological clinical trials, possessing limited understanding of virology, vaccines and pharmaceutical developmental processes, and any knowledge of antibodies had been long forgotten post-A-level biology. Yet overnight, the mass use and often misuse of such scientific jargon by the media became the norm, and the understanding of such convoluted subjects was no longer considered a requirement limited to health professionals only.
Welcome to the podcast revolution!
Sunday, 14 November marked World Diabetes Day, and this year’s theme was ‘ACCESS TO DIABETES CARE: IF NOT NOW, WHEN?’
Lung cancer is the most common cause of cancer-related death worldwide, of which the vast majority is non-small-cell lung cancer (NSCLC)(1). Early-stage NSCLC can be treated with surgery alone, while later stages are likely to also require adjuvant or combination therapies such as radiotherapy, chemotherapy and immunotherapy. If gene mutations are detected among cancer cells, then targeted therapy could also be administered.
The Corpus are delighted to again be recognised for our dedicated online medical education services. The judges at the Global Health & Pharma magazine have awarded The Corpus with an award for the Most Innovative Medical Virtual Meeting Platform in 2021.
The word ‘infographic’ gets used a lot in Med Comms. It sometimes feels like the ubiquitous solution to every challenge – big chunk of data, turn it into an infographic; latest study results, turn them into an infographic; promoting disease awareness, let’s make an infographic!
The days of large, dense chunks of text are long gone – no one has the time or the patience to wade through them. Instead we want an eye-catching infographic – enjoyable to read, easy to understand and visually striking.
Creepy robots, smart toilets, and the rise of digital therapeutics